MONDAY, Oct. 28, 2024 -- Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic...

FRIDAY, Oct. 25, 2024 -- Medication and behavioral therapy are both effective in combatting fatigue caused by multiple sclerosis (MS), either...

A study reveals that a low-salt fasting-mimicking diet slows kidney disease progression in animal models and shows protective effects in human...

FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue,...

Oliva will not be appearing with Savatage for their reunion set at Brazil's Monsters of Rock festival next year.

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can...

Newly published research in the journal Glia has identified crucial links between dietary choices and the progression of multiple sclerosis (MS).

FRIDAY, Nov. 1, 2024 -- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease...

FRIDAY, Nov. 1, 2024 -- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease...

P53 mutation increases colon cancer risk in ulcerative colitis patients, highlighting its crucial role in disease progression.